logo

Notable Earnings To Watch On July 24 - ORLY, T, BA, BSX, GD

Boston Scientific Corp. (BSX)
Boston Scientific Corp. (BSX)

Medical devices maker Boston Scientific Corp. (BSX) is scheduled to release its second-quarter results before the bell on Wednesday, July 24. Analysts estimate earnings of $0.38 per share and revenue of $2.64 billion for the quarter.

Q2 Outlook:

* Sees Q2 revenue growth between 5% and 7% on reported basis.
* Estimates organic revenue growth between 6% and 7%.
* Sees GAAP EPS in the range of $0.23 - $0.25.
* Sees Q2 adj. EPS of $0.37 - $0.39.

Year-Ago Numbers:

* Sales - $2.49 Bln
* GAAP Net Income - $555 Mln
* GAAP EPS - $0.40
* Adj. EPS - $0.41.

FY19 Guidance:

* Now projects FY19 revenue growth of 7% - 8% on reported basis versus prior view of 7% - 9%.
* Now sees revenue growth on an organic basis to be about 7%-8% versus prior guidance range of 7% - 8.5%; Consensus – 8.40%.
* Now expects FY19 GAAP EPS of $1.09 - $1.13 versus prior guidance range of $1.13 - $1.18/Shr.
* Expects FY19 adj. EPS of $1.54 - $1.58 versus prior view of $1.53 - $1.58/Shr; Consensus - $1.56/Shr.

Share



>